Valore202020212022202320242025TTMSpese di vendita, generali e amministrative2.47 B2.87 B3.89 B3.95 B2.97 B2.89 B2.89 BRicerca e sviluppo521 M534 M605 M667 M590 M518 M518 MReddito operativo1.62 B1.71 B-1.94 B390 M14 M-308 M-308 MProventi non operativi, Totale-272 M-45 M-56 M-30 M101 M81 M29 MOneri finanziari, al netto degli interessi capitalizzati153 M206 M415 M512 M408 M290 M—Proventi non operativi, esclusi gli oneri finanziari-235 M-210 M-456 M-491 M-345 M-250 M-182 MEntrate/uscite straordinarie-190 M-41 M-15 M-51 M38 M41 M41 MUtile al lordo delle imposte1.29 B1.48 B-2.35 B-103 M-289 M-505 M-505 MQuota di utile———————Imposte182 M182 M68 M-34 M37 M395 M395 MInteressi di minoranza8 M11 M12 M7 M11 M00Altri proventi/oneri al netto delle imposte-86 M-92 M12 M-77 M-41 M-30 M-30 MUtile netto al lordo delle attività cessate1.1 B1.28 B-2.43 B-76 M-337 M-900 M-900 MAttività cessate0——2.73 B-312 M-57 M-57 MUtile netto1.1 B1.28 B-2.43 B2.66 B-649 M-957 M-957 MRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari1.1 B1.28 B-2.43 B2.66 B-649 M-957 M-957 MUtile base per azione (EPS base)2.172.56-4.835.25-1.27-1.87-1.87Utile diluito per azione (EPS diluito)2.132.53-4.835.25-1.27-1.87-1.87Numero medio di azioni ordinarie in circolazione509 M502 M504 M506 M510 M513 M2.05 BAzioni diluite in circolazione517 M508 M504 M506 M510 M513 M2.06 BEBITDA1.31 B1.44 B-2.87 B-1.09 B-225 M-1 B-1.14 BEBIT488 M551 M-4.27 B-2.35 B-1.22 B-1.98 B-2.12 BCosto del fatturato7.09 B7.68 B9.72 B9.84 B6.65 B7.87 B7.87 BAltri costi del venduto———14 M9 M——Ammortamento e svalutazione (liquidità)823 M890 M1.4 B1.26 B997 M981 M981 M
Baxter International Inc
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.